Rytary on Horizon Medicare Blue Rx Enhanced (S5993-003)
carbidopa-levodopa extended-release
Covered.
Tier 4 (non-preferred drug). No quantity limit.
45%
Patient pays / month, after deductible
45%
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
RYTARY 95/23.75 mg Capsule, Extended Release at a preferred retail pharmacy. Other covered strengths are listed below.
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| RYTARY 95/23.75 mg Capsule, Extended Release | 4 | 45% | None |
| RYTARY 145/36.25 mg Capsule, Extended Release | 4 | 45% | None |
| RYTARY 195/48.75 mg Capsule, Extended Release | 4 | 45% | None |
| RYTARY 245/61.25 mg Capsule, Extended Release | 4 | 45% | None |
Other Parkinson's drugs on this plan
Verify with the plan before prescribing or filling. Member services: (800)391-1906. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5993-003